Home Blood Pressure Monitoring in Kidney Transplant Recipients
Reason given: Slow recruitment
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Oslo University Hospital
- Trial code
- NCT04364126
- Record updated
- 21 January 2026
- Original description
Randomized controlled study of home blood pressure monitoring in kidney transplant recipients.Read full original descriptionShow less
Home Blood Pressure Monitoring in Kidney Transplant Recipients to Alleviate Hypertension - a Pragmatic, Registry-based, Randomized Controlled Study
Randomized controlled study of home blood pressure monitoring in kidney transplant recipients.
Inclusion: Kidney transplant recipient; Male or female subject ≥ 18 years old; Any or more of the following at the baseline clinic; Conventional office BP ≥130 mmHg systolic and/or ≥ 80 mmHg diastolic; HBPM ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months (see appendix 1 for details on methodology); Daytime ambulatory blood pressure monitoring (ABPM) ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months; Signed informed consent and expected cooperation of the patient for the treatment and follow up; Have a national personal identification number and not be expected to emigrate during study; Enlisted in the Norwegian Renal Registry.
Exclusion: Current use of ≥ 4 antihypertensive medications; Female participant who is pregnant, lactating or planning pregnancy during the trial (management of essential hypertension in pregnancy is different); Any reason likely limiting adherence to interventions, as judged by the investigator; examples include active alcohol or substance abuse within the last 12 months, significant poor compliance with medications or attendance at clinic visits, residence in a nursing home, dementia, other medical or psychiatric conditions that may interfere with study participation; Severe white-coat hypertension, e.g. patients already treated solely based on home BP values; Multi-organ transplants (e.g. heart, lung, liver), though pancreas or beta-cell islet transplant is allowed; Standing systolic BP < 110 mmHg (to avoid adverse events). Measured after one and three minutes of standing. Not applicable if unable to stand due to wheelchair use; Diagnosed atrial fibrillation (automated monitors not validated); Unwilling to self-monitor; Arm circumference too large or small to allow accurate BP measurement with available device (22-42 cm); Graft- or life expectancy less than 2 years, as judged by the investigator; More than half of regular appointments planned as remote (e.g. phone or video) consultations.